Nebivolol Tablet
NDC Package 60687-652-21
Package Information
Nebivolol tablets is nebivolol is contraindicated in the following conditions:Severe bradycardiaHeart block greater than first degreePatients with cardiogenic shockDecompensated cardiac failureSick sinus syndrome (unless a permanent pacemaker is in place)Patients with severe hepatic impairment (Child-Pugh greater than B)Patients who are hypersensitive to any component of this product. This formulation utilizes a tablet delivery system. Marketed by American Health Packaging, this product is identified by NDC 60687-652 and is authorized under FDA application ANDA203828.
Identification & Billing
- RxCUI: 387013 - nebivolol 5 MG Oral Tablet
- RxCUI: 387013 - nebivolol (as nebivolol hydrochloride) 5 MG Oral Tablet
- RxCUI: 751612 - nebivolol 10 MG Oral Tablet
- RxCUI: 751612 - nebivolol (as nebivolol hydrochloride) 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 60687 - American Health Packaging
- 60687-652 - Nebivolol
- 60687-652-21 - 30 BLISTER PACK in 1 CARTON / 1 TABLET in 1 BLISTER PACK (60687-652-11)
- 60687-652 - Nebivolol
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 60687-652-21 identifies a specific commercial package of 30 blister pack in 1 carton / 1 tablet in 1 blister pack (60687-652-11) of Nebivolol, a human prescription drug labeled by American Health Packaging. This tablet is formulated for oral use and contains nebivolol hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by American Health Packaging on September 07, 2022. The current certification is valid through December 31, 2026.
How is this American Health Packaging product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 60687065221. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.